Brain Health Devices Market

1
Brain Health Devices Market Is Estimated To
Witness High Growth Owing To Rising Aging
Population Increasing Prevalence of
Neurological Disorders

• Brain Health Devices Market
• The global brain health devices market is
  estimated to be valued at US 9,070.5 million in
  2018 and is expected to exhibit a CAGR of 7.7
  over the forecast period 2019-2026, as
  highlighted in a new report published by Coherent
  Market Insights.
• Market Overview
• The brain health devices market includes devices
  used for the diagnosis and treatment of
  neurological disorders such as Alzheimer's
  disease, Parkinson's disease, and epilepsy. These
  devices play a crucial role in providing accurate
  diagnosis, monitoring brain activity, and
  delivering targeted therapy to patients. With the
  increasing prevalence of neurological disorders
  and a growing aging population worldwide, the
  demand for brain health devices is expected to
  rise significantly in the coming years.
• Market Dynamics
• 1. Driver Rising Aging Population
• The global population is rapidly aging, leading
  to an increased incidence of age-related
  neurological disorders. According to the World
  Health Organization (WHO), the number of people
  aged 60 years and above is expected to double by
  2050, reaching around 2.1 billion. This
  demographic shift is expected to drive the demand
  for brain health devices, as older adults are
  more prone to neurological conditions such as
  Alzheimer's and Parkinson's disease.

2

• 2. Opportunity Increasing Prevalence of
  Neurological Disorders
• Neurological disorders are on the rise globally,
  posing a significant burden on healthcare
  systems. According to the Global Burden of
  Disease Study 2016, neurological disorders are
  the leading cause of disability-adjusted life
  years (DALYs) worldwide. This increasing
  prevalence of conditions such as epilepsy,
  dementia, and stroke creates opportunities for
  the brain health devices market to develop
  innovative diagnostic and therapeutic solutions.
• Segment Analysis
• The brain health devices market can be segmented
  based on product type, application, and end-user.
  Among the product types, neurostimulation devices
  dominated the market in 2018. Neurostimulation
  devices, such as deep brain stimulation (DBS) and
  transcranial magnetic stimulation (TMS), are
  widely used for the treatment of neurological
  disorders. These devices offer targeted therapy
  and have shown promising results in managing
  conditions such as Parkinson's disease and
  depression.
• PEST Analysis
• Political The political landscape plays a
  crucial role in determining the regulatory
  environment for brain health devices. Regulations
  related to the approval and reimbursement of
  these devices vary across different regions,
  impacting market growth.
• Economic The economic factors impacting the
  brain health devices market include healthcare
  expenditure, GDP growth, and disposable income. A
  growing economy and increased healthcare spending
  contribute to the growth of the market.
• Social The social factors encompass the impact
  of lifestyle changes, awareness about
  neurological disorders, and the acceptance of
  advanced technologies among healthcare
  professionals and patients. Rising awareness
  about brain health and the importance of early
  diagnosis drive the demand for brain health
  devices.
• Technological Advancements in technology,
  including brain-computer interfaces, wearable
  devices, and artificial intelligence, are
  revolutionizing the brain health devices market.
  These innovations are improving diagnosis
  accuracy, treatment outcomes, and patient
  experience.
• Key Takeaways
• The global brain health devices market is
  expected to witness high growth, exhibiting a
  CAGR of 7.7 over the forecast period, due to the
  increasing aging population and the rising
  prevalence of neurological disorders.

3
3. Key players operating in the global brain
health devices market include CAS Medical Systems
Inc., Advanced Brain Monitoring Inc., Covidien
PLC, Cadwell Laboratories Inc., Elekta AB, GE
Healthcare, Masimo Corporation, Natus Medical
Inc., Integra LifeSciences Holdings Corporation,
NeuroWave Systems Inc., Philips Healthcare, Nihon
Kohden Corporation, and Siemens Healthineers. In
conclusion, the growing aging population and
increasing prevalence of neurological disorders
are driving the demand for brain health devices.
Advancements in technology and rising awareness
about brain health further contribute to market
growth. The market offers significant
opportunities for innovation and development of
new products to cater to the needs of patients
with neurological conditions.